Ser8
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9.3
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser8  -  CDK5R1 (human)

Site Information
MGTVLSLsPSYRKAT   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 471392

In vivo Characterization
Methods used to characterize site in vivo:
2D analysis ( 7 ) , immunoprecipitation ( 1 , 4 , 6 ) , mass spectrometry ( 5 ) , mutation of modification site ( 3 , 4 , 6 , 7 ) , phospho-antibody ( 3 , 4 ) , western blotting ( 1 , 2 , 3 , 4 )
Disease tissue studied:
adrenal cancer ( 6 ) , pheochromocytoma ( 6 ) , neuroblastoma ( 1 )
Relevant cell line - cell type - tissue:

Upstream Regulation
Regulatory protein:
CDK5 (human) ( 1 )
Putative in vivo kinases:
CDK5 (human) ( 3 , 7 )
Kinases, in vitro:
CDK5 (human) ( 6 )

Downstream Regulation
Effects of modification on CDK5R1:
enzymatic activity, induced ( 2 ) , intracellular localization ( 3 ) , molecular association, regulation ( 4 ) , protein conformation ( 4 ) , protein stabilization ( 7 )
Effects of modification on biological processes:
cytoskeletal reorganization ( 4 )

References 

1

Takasugi T, et al. (2016) Two Degradation Pathways of the p35 Cdk5 (Cyclin-dependent Kinase) Activation Subunit, Dependent and Independent of Ubiquitination. J Biol Chem 291, 4649-57
26631721   Curated Info

2

Takada S, et al. (2015) Effects of p35 Mutations Associated with Mental Retardation on the Cellular Function of p35-CDK5. PLoS One 10, e0140821
26469698   Curated Info

3

Asada A, Saito T, Hisanaga S (2012) Phosphorylation of p35 and p39 by Cdk5 determines the subcellular location of the holokinase in a phosphorylation-site-specific manner. J Cell Sci 125, 3421-9
22467861   Curated Info

4

He L, et al. (2011) The neuronal p35 activator of Cdk5 is a novel F-actin binding and bundling protein. Cell Mol Life Sci 68, 1633-43
20976519   Curated Info

5

Guo A (2010) CST Curation Set: 6259; Year: 2010; Biosample/Treatment: cell line, 293/mTOR inhibitor; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: (F/Y)p[ST] Antibodies Used to Purify Peptides prior to LCMS: Phospho(Ser/Thr) Phe Antibody Cat#: 9631
Curated Info

6

He L, Hou Z, Qi RZ (2008) Calmodulin binding and Cdk5 phosphorylation of p35 regulate its effect on microtubules. J Biol Chem 283, 13252-60
18326489   Curated Info

7

Kamei H, et al. (2007) Suppression of calpain-dependent cleavage of the CDK5 activator p35 to p25 by site-specific phosphorylation. J Biol Chem 282, 1687-94
17121855   Curated Info